# eMAR completion — 3 October 2026

Active implementation programme. This is not a completion or release claim.

Stephan asked Main to audit and finish Claude's eMAR work, improve UI/UX using Rory's rules and existing mockups, orchestrate GPT-6.1 Sol Extra high sessions, pin active sessions and unpin completed ones, and push reviewed work. He subsequently delegated approvals while away. This authorises routine design and implementation decisions; approved care policies remain intact.

Baseline: `9747cf7cb654c2ef441e8f60c7ea1b5918081925` (fetched origin/main). Main integrates serially in `C:/Users/steph/.codex/worktrees/emar-completion-integration/oblivionfindings`, branch `codex/emar-completion-20261003`.

The previous audit and Claude's chronological decisions are preserved under `docs/emar-audit-2026-09-28/claude-second-review/`. Read latest decisions and exact approved design versions, not the first historical entry. Current source and tests take precedence over obsolete findings.

## Working ownership

- Inventory: all fourteen approved mockups, source refs, unfinished work and dependency map.
- P01: Meds today, recording, rounds and My Day integration.
- P02: person medication record, MAR/hub/profile and its recording seam; recover Claude's unfinished implementation.
- P11: remaining settings, alert log, eligibility and emergency-policy settings; recover Claude's unfinished implementation.
- Security: PIN-2 and independent medication security review.
- P03: support and self-administration.
- P04: orders and reconciliation.
- P06: stock, pharmacy and approved medicine photographs.

P07a/P07b, P08a, P08b, P05, P09 and P10 now have separate pinned implementation sessions. The inventory session has moved to independent review of the first recovered commits. Session identities and current state are in `session-registry.json`. Only Main integrates/pushes. Shared controllers/routes are reviewed during each integration; sessions cannot push directly.

The integration baseline passes TypeScript after generating its local Wayfinder helpers. Application and TestCase reflection paths resolve to the integration checkout's own physical dependency copy. Herd responds at its normal host; integrated UI verification will use a separate synthetic database and explicit checkout/asset identity.

Automatic approval review rejected P06's new stock role grants because delegated design records did not establish specific role authorization. Existing stock.update access is preserved while the rest of P06 proceeds. Do not silently claim frontline receive/expanded house-lead grants are enabled.

Automatic approval review also rejected widening unassigned-round administration. The existing server gate is retained. Readable task visibility must explain the assignment restriction without implying authority to administer.

## Integration checkpoint — 02:40 NZ, 4 October

Main integrated all twelve browser-repair candidates and applied the opt-in frontline header to Meds today, the person record and Orders. The independent meter-width finding is corrected without shrinking the 140px information blocks. UI snapshot `a413e576f` ran 59 suites: 56 passed, 3 failed; 393 cases passed, 5 failed. New header/mobile-card/Settings renderer regressions passed. Five review-dialog cases also passed with the production React compiler enabled. The five remaining UI failures concern older recorder/covert source contracts and the syringe-driver witness contract; their proper replacements require review, not deletion of assertions.

The consolidated backend run at `92466adc2` completed: **1518 passed, 393 failed, 16563 assertions, 4565.53 seconds**. The complete console failure inventory has 393 records across 78 files. JUnit has all suite failure totals but omitted detailed later testcases; its 1238-case/283-detailed-failure extraction must not replace the console totals. The source is not release-ready. The long final silent interval ended normally; the test process was not interrupted.

Main fixed the unsupported receipt validation rule and adjacent Blade directives in the MAR allergy template (`358d71bb5`), then corrected two UTC test clock fixtures while preserving the same NZ instant (`5cd993c27`). Runtime verification of these fixes is pending. A full TypeScript/build run started at `358d71bb5`; subsequent changes are test-only.

Independent review found three additional repairs: single-event export must derive its release scope from the actual event, the downtime digest must cover canonical allergy details, and existing paper-evidence mutations must reload authorization after lock waits. The security owner is repairing these without enabling held historical posting. Safety overview has a separate UI-only header/navigation repair. Inventory is classifying the backend failure groups before bounded repair delegation.

All automatic-review holds below remain unchanged. No push, production deployment or completion claim has been made.

### Historical checkpoint — 02:03 NZ, 4 October

The combined source is frozen at `92466adc2` for Main's consolidated backend run. Full TypeScript and a production Vite build passed at `e52054efc`; later P05/P08b backend/export fixes are integrated. The backend run remains active and already shows failures; no passing combined runtime claim is made. Migration regression cases rebuild the isolated test database, accounting for long intervals without progress output. Main is letting this run complete before clustering failures and changing source.

Browser testing uses the separate synthetic preview and built assets identified in `browser-verification.md`. Worker navigation is reduced to Meds today; management has seven medication hubs. A synthetic scheduled dose travelled through the mobile recorder, confirmation, person MAR and activity. A synthetic PRN dose required an explicit effect-check time, created an owned follow-up, completed through the canonical follow-up dialog and updated the queue and dose-spacing display. These are actual UI observations, not all-workflow certification.

Browser defects being repaired include the first-open review dialog crash, initial Settings crash, P02 chart page overflow on phones, small frontline header targets, missing mobile activity/PRN/follow-up cards, dark header captions, ambiguous disabled-order guidance and misleading empty-state/eligibility copy. Source repairs are queued separately while Main's backend snapshot remains frozen. Historical MAR wording now has a separate P02 candidate using checked prescription versions; it awaits integrated regression verification.

The automatic-review holds below remain in force. No held controlled, stock, emergency/PIN, historical paper-posting or entered-in-error writer has been substituted under another path. The branch is not pushed or released yet.

### Historical checkpoint — 01:06 NZ, 4 October

Current candidate: `ac3b0a8a6`. The reviewed P03 replacement `fa947cb9a` is integrated as `94964b4f1`: it preserves legacy self-management throughout. The rejected intermediate was never applied. Full P02 clinical, allergy, MAR hub and history candidates are integrated; legacy allergy/INR and cadence seam repairs are still being finalised. Report changes now route generic medication exports through the purpose flow, enforce medication-error account visibility, recheck approval before releasing bytes, and connect the guarded downtime-pack preview.

At `4a052ef20`, all 338 changed PHP files passed syntax checks and all 216 eMAR routes registered. Full TypeScript at the previous `f469adc80` failed with five UI API mismatches; the governance submit chain is repaired and P02 owns its four remaining contract corrections. The private dependency copy is stable. No full combined TypeScript/build/backend/browser pass is claimed yet.

Additional automatic-review holds remain explicit and unapplied: P07 reduced clinical repair `277d20ba1b` (controlled-dose linking, waste witness and PRN validation); P01 `d32897b78` (emergency/offline expiry recovery and forgotten-PIN behavior); P10 historical paper-to-clinical writer; and P08b entered-in-error writer. Specific human approval questions are pending. The P07 type-only `60c8420ad` is integrated. P10's safe `2b9d241c8` retains immutable paper evidence with a truthful pending reason and does not post a clinical dose. None of these held workflows is represented as complete.

Heavy commands remain serialized. Main is preparing one consolidated backend run covering eMAR plus its medication, My Day, transport, calendar, reporting and Tasks consumers. Active chats are P02, P05 (legacy cadence) and P08b (legacy export protection); completed chats are unpinned. Primary application data remains untouched.

### Historical checkpoint — 00:34 NZ, 4 October

Current review branch: `26fd90551`. This supersedes the historical checkpoint below. Integrated candidates now include the full P10 lifecycle/downtime foundation; P01 ordinary pack allocation and My Day/Tasks/Calendar links; P06 legacy scalar-write guards, current availability and atomic multi-batch ordinary receipts; P08a emergency-use checks and PIN-2 consumer; P05 preserved cadence and locked authority repairs; P11 scoped navigation; unified role-aware hubs; independent recovery tests; and temporal PRN safety checks. These are provisional source integrations, not a clinical release.

The isolated synthetic database `oblivion_emar_preview_20261003` passed all then-pending migrations at `6d70a8aba`. No primary application database was migrated. Later migrations and all combined browser acceptance remain pending. A combined TypeScript check is running against the private dependency copy; no current integrated pass is claimed.

The shared heavy-command helper incorrectly parsed multi-word labels and could treat a live holder as stale. Main paused new heavy runs, allowed the owned active tests to finish, installed the exact suffix-PID parser atomically, and passed a two-job isolated serialization smoke. Remaining backend suites will run together against the final combined snapshot; workers must not restart separate cold database runs.

The primary shared `node_modules` unexpectedly became empty at approximately 00:22, then again after a successful lockfile restore. Cause is not established. Main preserved its junction under `node_modules.shared-link-20261004` and installed a private physical copy from the unchanged lockfile with install scripts disabled. No unrelated process was stopped. The failed TypeScript runs before private installation were environment failures, not passes or accepted source defects.

P03's unsafe intermediate `7e9ee890d` remains unintegrated: applying it before its later repair could reinterpret legacy self-management. Automatic review rejected the sequential pair; the owner is preparing one final-state alternative that preserves old support throughout, with regression evidence. P07 mixed `7aa5f2439`/`7bbe13cf3` is also excluded: Main aborted only its uncommitted cherry-pick after automatic review identified receipt-related changes. The owner is separating unaffected witness/FK/UI repairs from held receipt and physical-stock changes.

Automatic-review holds also include P06 alert-source/after-commit rewrites, controlled receipt/pack-writer connections, deleted/superseded medication recording expansion, new stock role grants and unassigned-round administration expansion. Held changes stay unapplied; stock and PIN activation remain off until their integration and acceptance requirements are met. Exact proposals are preserved for review. No permission is inferred from the user being asleep.

Focused runtime evidence remains mixed: P05's previous run had 28 booking failures; P08b had 10 failures/41 warnings; P08a had four failures; P09 had one failure. Owners supplied or are preparing repairs. Missing-environment warnings and unrun regression cases remain explicit. Final source/type, runtime, browser and visual evidence is required before pushing a release-ready claim.

Completed implementation/review chats are unpinned; active and reactivated reviewers remain pinned. Current session status is recorded in `session-registry.json`.

### Historical checkpoint — 23:55 NZ

The integration branch at `65bad49ef` contains provisional P01–P07, P08b, P09 and P11 candidates plus the shared P08a follow-up and P10 policy foundations. P08a's full screen and P10's full lifecycle/downtime candidate are still incoming. It is not pushed. Shared recorder, configuration, scheduled jobs, Settings and Tasks provider conflicts were resolved by preserving compatible implementations together. Remaining owner fixes and connected workflow checks are required before acceptance.

An earlier candidate's 103 changed PHP files passed syntax checks and 156 eMAR routes loaded; this does not cover the later integrations. The synthetic preview database was prepared separately. Guarded pending migrations are queued for that named database only; combined frontend build and browser checks are still pending. No application data was migrated or reseeded in the primary checkout.

The frozen frontend snapshot at `69cc7bb0d` failed TypeScript with recorder, MAR fixture, error-tab tuple, review-error-map and support-form transform errors; each is assigned to its owner. A missing diagram fixture was a snapshot-copy limitation, not an application failure. No integrated frontend pass is claimed.

P03 now writes durable support-review receipts inside the source transaction and delivers/retries through a scheduled worker. P04 review recommendations link actual order changes, cessation and replacement evidence. MySQL foreign-key names in its migrations were repaired. P09 report/export candidate rechecks final access and dataset evidence, with new cross-module datasets still being connected. P11's merge preserves both controlled-medicine and emergency-policy authority checks plus existing global/site checks; an initial ambiguous scripted resolution was rejected by automatic review and replaced with explicit composition.

Main reactivated and pinned the inventory/UI chat for unified navigation, canonical report/audit links and role-specific entry tests. The clinical review/map chat is complete and unpinned. The recovery reviewer is independently testing combined correction audit rollback, same-house person privacy and PIN/controlled-witness boundaries. Those tests are acceptance evidence, not permission to relax boundaries.

Independent findings and current evidence are recorded in `independent-integration-review.md`, `independent-clinical-review.md`, `independent-ui-review.md` and `independent-recovery-review.md`. Source corrections are distinguished from verified runtime outcomes. First focused runs found migration-name failures, bell ordering and a support-test failure; they are not recorded as passes.

## Verification and preservation

Heavy tests/builds run one at a time through the existing machine-wide FIFO resource lock with at least 5.5 GB free memory. Use isolated databases and synthetic scenarios. Never confuse a shared-vendor autoloader resolving the primary checkout with testing a worktree. Preserve original Claude WIP and other projects. No force push or destructive live-data migration.

Desktop checks follow the approved 1440/1280/200% zoom scope; existing responsive behaviour is retained. Main must verify integrated workflows and compare actual screens to approved mockups before declaring completion. All missing proof, deferred decisions and deployment/setup actions remain explicit.

### 4 October03:05 checkpoint

Frontend snapshot87c8102c5 passed full TypeScript and production build. Mobile cards/44px controls, Settings and review-booking repairs verified in browser; final day-chart containing-block repair25b253d80 still needs rebuild/acceptance. Complete backend393-failure/78-file manifest is integrated06c0a24e9. Focused StockPacksWorkflow atd51d5e9da ran27cases:26passed,1failed (238assertions,347.09s); the remaining closed-order field/message contract is repairedfd6af77f9, pending rerun. Security source fixes a3dfff4fd/7d2d9e33d/b90d1de32 now integrated; focused runtime checks pending. No push or release yet. Existing approval holds remain.

### 4 October 03:39 verification checkpoint

At50ee59735, the ten-suite focused backend batch completed143cases:133passed,10failed,1022assertions,456.02s. StockPacksWorkflow27/27, PharmacySupplyRules, PersonMedicationRecord13/13, allergy endpoint, MedicineRuleSettings and MAR PDF export tests passed. The remaining ten failures were test snapshots, missing fixture actor, final-class mocking and fixtures that did not actually mutate their intended evidence; Main repaired them7789ba63d, runtime rerun pending.

At7789ba63d, UI59suites ran398cases:396passed,2failed. The final two obsolete expectations were corrected38d0530e8; both suites then passed17/17. New stock phone-card coveragec9c48d905 awaits its separate run. The previous full type/build pass was87c8102c5; later UI changes await rebuild.

P05's four reviewed test commits are integrated451b2ea4d/86f834615/3928ed64b/fd527f4af. Main's12-suite second backend batch started atfd527f4af. Subsequentc9c48d905 is UI-only and does not change that backend snapshot. P04, P09 and P11 are active; other chats unpinned. Confirmed new source issues include an omitted existing verification permission in locked reconciliation evidence, Settings capability shadowing, and historical clinical audit rows inaccessible from the new event-only hub. Owners are repairing these with exact authority and preserved evidence; no blanket test weakening. All previously documented automatic-review holds remain. No push or clinical release claim yet.

### 4 October 2026, 04:09 NZDT — integration checkpoint

Third focused backend batch at dc0131474: 170 cases, 166 passed and four fixture failures, 1,540 assertions, 511.34 seconds. ControlledProduct, MedicationErrors, MedicationFollowupWorkflow, PrnRecordsHistory and MedicationOrdersWorkflow all passed. The remaining MedicationSupportWorkflow failures were two misplaced snapshot fixture lines and two error-report fixtures without the required clocked shift. These were repaired in de460cdb5; no production authority changed.

Reviewed P11 notification, Settings navigation and query reuse candidates are integrated as 0f159cc9a, 40f379479 and 1f100ffba. The fourth focused batch covers nine P11 suites plus MedicationSupportWorkflow at de460cdb5. Its PowerShell count banner says one because of JSON array wrapping; the actual PHP process arguments were inspected and contain all ten intended test paths. No result is yet claimed.

Actual browser CSV download verified in Downloads with NZ date/time fields. Actual downtime PDF rendered: page numbers and controlled continuation identity now print, but Dompdf still orphans some blank PRN recording table bodies from their headings. A keep-together repair is prepared, pending the frozen backend run and a fresh downloaded PDF visual check. No paper writer activation is included.

Active pinned workers: P01, P04 and P09. P11 is finished and unpinned. Previously documented automatic-review holds remain unchanged; no push, production release or full backend pass is claimed.

### 4 October 2026, 04:40 NZDT — verification checkpoint

The full interface run at 8c00c1eee passed all 60 suites / 403 tests (148.18 seconds). TypeScript and production frontend build passed at f5da61fff; build asset app-DaT9aSj3.js. Historical report date-filter UI and the subsequent stock grid correction still require the next build.

Fourth focused backend batch at de460cdb5: 146 cases, 142 passed / four failed, 1,538 assertions, 446.37 seconds. MedicationSupportWorkflow now passes, as do emergency lifecycle/notifications, medication alerts, Settings storage/site/auditor access and event integration. Existing query ceilings (110 and 33) passed unchanged. The four remaining failures were fixtures: three navigation assertions used can.medications instead of the actual shared auth.can.medications path; the fourth requested an invalid all-channels-off routing value. Main fixed these in 5e039a7ee and added a fallback regression. Correction to the earlier suspected navigation defect: the shared capability was nested under auth.can and was not overwritten; the settingsCan rename is a clearer page contract, not evidence of a real sidebar overwrite.

The fifth backend batch is frozen at 3cadf9555 and covers 20 order, reporting, NZ date-boundary and Settings suites. It uses pwsh to preserve the exact test-path array. Its isolated database is oblivion_findings_codex_test_40508; setup progress was confirmed via its process list. No result yet.

Browser observations on the rebuilt assets: person day and week chart pages fit CSS390/document378 with locally scrolling tables; Settings and Records & reporting render at CSS390/document378 without a new console error. Stock phone cards exposed an outer implicit-grid width defect (document959); the one-line explicit grid-column constraint is committed as 3cadf9555 and awaits rebuilt browser proof. Paper pack download/identity/page-number proof is complete in browser-verification.md.

P01, P07 and P09 are active; completed workers are unpinned. P01 supplied seven test-only candidates, queued for review/integration after this frozen run, and is investigating two fixed-query regressions without relaxing their assertions. P07 retains all writer approval holds. No push or production-readiness claim yet.

### 4 October 2026, 04:53 NZDT — fifth batch and follow-up

Fifth batch at3cadf9555 completed212cases:198passed,14failed,4,242assertions,512.77seconds. New historical audit export NZST/NZDT/23-hour-day and5,001-row CSV tests passed. P11NavigationPayload and MedicationAlertRouting now pass. All order verification, controlled-order mutation authorization, NZ calendar, demo-seeder, database and controlled-report authorization tests pass. Remaining failures: order lifecycle1, prescriptions2, audit omissions3, audit trail1, governance readers2, report canonical scope2, round slots2 and unified PDF release1. Exact evidence remains in emar-fifth-repair.log/xml.

P01's seven reviewed fixture/provider commits are integrated b90172ef0,f00054258,c36f5bff5,2fb906251,400783e21,299532929,6892f7e21. P04's OneChart pending-source fixture11306ddca and P09's15 controller reader/export repairs7eb1d5ca4 are also integrated. Evidence reconciliation corrected an internal overstatement: OneChartAdministrationSafety was not in the earlier second-batch XML; OneChartGovernanceWorkflow was. AdministrationSafety is explicitly queued for the next run and is NOT claimed passed.

Main confirmed a real covert-revocation regression: the current-order workflow blocked withdrawal of authorisations on superseded/deleted orders.53f8fe03c restores the existing forCovertAuthorisation scope for this termination operation, preserves exact user/site/person/controlled capabilities and immutable prescription rows, and completes the canonical audit/followup event. This does not open a medication administration or order-modification writer. The legacy incomplete covert-create request still redirects to complete source evidence and creates nothing.

9ac2d103d migrates the retained lifecycle CSV fixture to the guarded canonical export and corrects the PDF release test so the medicine existed before its scheduled dose. The test now explicitly proves that the person is in the rendered dataset before simulating a move; the409/no-byte-release assertion remains.

4157f7290 applies New Zealand report-period bounds to the retained discrepancy CSV and names the displayed timezone; new cases cover both DST transitions and a501-row complete export. P07 controller fixture commit079ef7dc6 is integrated with all P04/P09 imports and methods preserved. Frontend build remains frozen at a4eb818e2; only backend/test changes followed it. Next26-suite runtime batch pending.

## Current status pointer — 05:20 NZ, 4 October

Read CURRENT-STATUS.md for the current verification and hold ledger. The dated checkpoints above are historical and do not constitute the current release status. Sixth batch completed at e734a69b6: 450 passed, 25 failed, 5,983 assertions. P01, P07 and P09 own the remaining bounded repairs; security's focused historical revocation/export review found no actionable issues. Main has integrated reviewed fixture commits ee5fff402, 1b1ad4423, a4742baf6, a3d465d82 and 19a01ab6a for the next run. No push or clinical release yet.
